For Good Ventures
Late Stage
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Longevity ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathElevian is a biotechnology company developing rGDF11, a recombinant protein therapy shown in preclinical animal models to promote recovery of motor function after ischemic and hemorrhagic stroke by stimulating new blood vessel formation, neurogenesis, and reducing inflammation.
BiotechHealthtechLongevityMenlo Park, US
Mark Allen(Executive Officer, Director)Casey J McGlynn(Executive Officer)Sebastian Giwa(Executive Officer, Director)Luis Alvarez(Executive Officer)Daniel Marshak(Director)
BoardSuzanne Fletcher(Director)
Portfolio news
latest coverage across their companiesElevian · nasdaqprivatemarket.com · Jun 27, 2025
Frequently asked questions
- What stage does For Good Ventures invest at?
- For Good Ventures invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.